Advertising and Donations - advertising-newsandtimes.com

President Donald Trump is meeting Friday with Nvidia CEO Jensen Huang, whose company designs and supplies the advanced computer chips that play an integral role in developing artificial intelligence. The meeting at the White House was confirmed by a person familiar who insisted on anonymity to discuss the conversation between Huang and Trump. The p…

By Marianna Parraga and Elida Moreno (Reuters) -Some U.S. lawmakers and officials are touting a nearly half-century-old treaty between the United States and Panama to justify the Trump administration’s threat to reclaim the Panama Canal – provided it can show the strategic waterway’s operation is under threat. Others, however, say hurdles would loom for any bid to use the 1977 Panama Canal

The union representing air traffic controllers on Friday rebutted President Trump’s unsubstantiated claim that diversity policies in aviation were to blame for the fatal plane crash Wednesday near Washington, D.C. The big picture: The union’s president defended the quality of his workforce while acknowledging its staff shortages. A federal investigation is still underway to determine the cause of the deadliest aviation crash in the U.S. in…

Crews returned to the Potomac River on Friday as the search continues for any debris tied to the deadly midair collision near Reagan National Airport.

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuti…

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuti…

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuti…

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuti…

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuti…

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuti…